Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
19.96
+0.56 (2.89%)
At close: Jun 26, 2026, 4:00 PM EDT
19.87
-0.09 (-0.45%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Immunome Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Immunome stock have an average target of 35.36, with a low estimate of 30 and a high estimate of 40. The average target predicts an increase of 77.15% from the current stock price of 19.96.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunome stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 12 | 12 | 12 | 10 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 14 | 14 | 15 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $31 | Buy | Maintains | $31 | +55.31% | Jun 12, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $39 | Buy | Reiterates | $39 | +95.39% | Jun 12, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $36 | Buy | Reiterates | $36 | +80.36% | Jun 11, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $20 → $40 | Buy | Maintains | $20 → $40 | +100.40% | Jun 11, 2026 |
| Lake Street | Lake Street | Buy Maintains $30 | Buy | Maintains | $30 | +50.30% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
2.72M
from 6.94M
Decreased by -60.86%
Revenue Next Year
67.35M
from 2.72M
Increased by 2,379.24%
EPS This Year
-2.12
from -2.43
EPS Next Year
-2.10
from -2.12
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 26.6M | 144.0M | |
| Avg | 2.7M | 67.4M | |
| Low | n/a | 8.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 283.2% | 5,200.6% | |
| Avg | -60.9% | 2,379.2% | |
| Low | -100.0% | 194.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.84 | -1.71 | |
| Avg | -2.12 | -2.10 | |
| Low | -2.45 | -2.71 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.